These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10711661)

  • 1. Growth hormone treatment in short children with beta-thalassemia major.
    Katzos G; Papakostantinou-Athanasiadou E; Athanasiou-Metaxa M; Harsoulis F
    J Pediatr Endocrinol Metab; 2000 Feb; 13(2):163-70. PubMed ID: 10711661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts.
    Tönshoff B; Haffner D; Mehls O; Dietz M; Ruder H; Blum WF; Heinrich U; Stöver B
    Kidney Int; 1993 Jul; 44(1):199-207. PubMed ID: 7689125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone treatment in children with thalassemia major.
    Arcasoy A; Ocal G; Kemahli S; Berberoğlu M; Yildirmak Y; Canatan D; Akçurin S; Akar N; Uysal Z; Adiyaman P; Cetinkaya E
    Pediatr Int; 1999 Dec; 41(6):655-61. PubMed ID: 10618886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.
    De Muinck Keizer-Schrama S; Rikken B; Hokken-Koelega A; Wit JM; Drop S
    Arch Dis Child; 1994 Jul; 71(1):12-8. PubMed ID: 8067786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone secretion in polytransfused prepubertal patients with homozygous beta-thalassemia. Effect of long-term recombinant GH (recGH) therapy.
    Masala A; Atzeni MM; Alagna S; Gallisai D; Burrai C; Mela MG; Rovasio PP; Gallo P
    J Endocrinol Invest; 2003 Jul; 26(7):623-8. PubMed ID: 14594112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose growth hormone treatment of short children born small for gestational age.
    de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.
    Soliman AT; El Banna N; Abdel Fattah M; ElZalabani MM; Ansari BM
    Metabolism; 1998 May; 47(5):541-8. PubMed ID: 9591744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.
    Cavallo L; Gurrado R; Gallo F; Zacchino C; De Mattia D; Tatò L
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):701-6. PubMed ID: 9274700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with beta-thalassemia major.
    Kwan EY; Tam SC; Cheung PT; Low LC
    J Pediatr Endocrinol Metab; 2000 May; 13(5):545-52. PubMed ID: 10803873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.